Vokes E - Search Results

1

PROCLAIM: Randomized Phase III Trial of Pemetrexed-Cisplatin or Etoposide-Cisplatin Plus Thoracic Radiation Therapy Followed by Consolidation Chemotherapy in Locally Advanced Nonsquamous Non-Small-Cell Lung Cancer.

Senan S, Brade A, Wang LH, Vansteenkiste J, Dakhil S, Biesma B, Martinez Aguillo M, Aerts J, Govindan R, Rubio-Viqueira B, Lewanski C, Gandara D, Choy H, Mok T, Hossain A, Iscoe N, Treat J, Koustenis A, San Antonio B, Chouaki N, Vokes E. Senan S, et al. Among authors: vokes e. J Clin Oncol. 2016 Mar 20;34(9):953-62. doi: 10.1200/JCO.2015.64.8824. Epub 2016 Jan 25. J Clin Oncol. 2016. PMID: 26811519 Clinical Trial.

2

The evolving role of systemic therapy in carcinoma of the lung.

Haraf DJ, Devine S, Ihde DC, Vokes EE. Haraf DJ, et al. Among authors: vokes ee. Semin Oncol. 1992 Aug;19(4 Suppl 11):72-87. Semin Oncol. 1992. PMID: 1324527 Review.

3

Investigation chemotherapy in multimodality therapy of non-small cell lung cancer.

Vokes EE. Vokes EE. Front Radiat Ther Oncol. 1992;26:64-71. Front Radiat Ther Oncol. 1992. PMID: 1324877 Review. No abstract available.

4

Intravenous 6-thioguanine or cisplatin, fluorouracil and leucovorin for advanced non-small cell lung cancer: a randomized phase II study of the cancer and leukemia group B.

Vokes EE, Lyss AP, Herndon JE 2nd, Cooper B, Perry MC, Vinciguerra V, Mason-Coughlin K, Green MR. Vokes EE, et al. Ann Oncol. 1992 Nov;3(9):727-32. doi: 10.1093/oxfordjournals.annonc.a058328. Ann Oncol. 1992. PMID: 1333267 Free article. Clinical Trial.

5

Favorable long-term survival following induction chemotherapy with cisplatin, fluorouracil, and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancer.

Vokes EE, Weichselbaum RR, Mick R, McEvilly JM, Haraf DJ, Panje WR. Vokes EE, et al. J Natl Cancer Inst. 1992 Jun 3;84(11):877-82. doi: 10.1093/jnci/84.11.877. J Natl Cancer Inst. 1992. PMID: 1375657 Clinical Trial.

6

Chemotherapy in head and neck cancer.

Hamasaki VK, Vokes EE. Hamasaki VK, et al. Among authors: vokes ee. Curr Opin Oncol. 1992 Jun;4(3):504-11. doi: 10.1097/00001622-199206000-00013. Curr Opin Oncol. 1992. PMID: 1498159 Review.

7

Perspectives on combination chemotherapy with concomitant radiotherapy for poor-prognosis head and neck cancer.

Vokes EE, Haraf DJ, Weichselbaum RR, McEvilly JM, Sutton HG, Panje WR. Vokes EE, et al. Semin Oncol. 1992 Aug;19(4 Suppl 11):47-56. Semin Oncol. 1992. PMID: 1509281

8

Neoadjuvant PFL augmented by methotrexate and piritrexim followed by concomitant chemoradiotherapy for advanced head and neck cancer: a feasible and active approach.

Vokes EE, Haraf DJ, McEvilly JM, Mick R, Kozloff MF, Goldman MD, Moran WJ, Clendeninn NJ, Collier MA, Weichselbaum RR, et al. Vokes EE, et al. Ann Oncol. 1992 Jan;3(1):79-81. doi: 10.1093/oxfordjournals.annonc.a058079. Ann Oncol. 1992. PMID: 1606074 Clinical Trial.

9

Serum immunoerythropoietin levels in patients with cancer receiving cisplatin-based chemotherapy.

Smith DH, Goldwasser E, Vokes EE. Smith DH, et al. Among authors: vokes ee. Cancer. 1991 Sep 1;68(5):1101-5. doi: 10.1002/1097-0142(19910901)68:5<1101::aid-cncr2820680533>3.0.co;2-l. Cancer. 1991. PMID: 1655216

10

Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for locally advanced head and neck cancer: a clinical and pharmacologic analysis.

Vokes EE, Schilsky RL, Weichselbaum RR, Kozloff MF, Panje WR. Vokes EE, et al. J Clin Oncol. 1990 Feb;8(2):241-7. doi: 10.1200/JCO.1990.8.2.241. J Clin Oncol. 1990. PMID: 1688926

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

632 results

Search Page